Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary subglottic cancer

J D Dahm1, D G Sessions, R C Paniello

  • 1Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

The Laryngoscope
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tonsillotomy: facts and fiction.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2014
Same author

Monitoring air, soil, stream and fish for aerial drift of permethrin.

Environmental monitoring and assessment·2013
Same author

Inclusive search for supersymmetry using razor variables in pp collisions at √s=7 TeV.

Physical review letters·2013
Same author

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV.

Physical review letters·2013
Same author

Search for pair production of third-generation leptoquarks and top squarks in pp collisions at sqrt[s] = 7 TeV.

Physical review letters·2013
Same author

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV.

Physical review letters·2013
Same journal

Superior Labial Artery Flap for Septal Perforation Repair: The Boxer's Flap.

The Laryngoscope·2026
Same journal

3 French Suction Technique for Alignment of the OSIA Bone Conduction Hearing Implant: How I Do It.

The Laryngoscope·2026
Same journal

Orticochea Flap for Reconstruction of Large Scalp Defects: Outcomes and Technique.

The Laryngoscope·2026
Same journal

Rising Pediatric Button Battery Injuries Despite Safety Efforts: An Analysis of National Injury Data.

The Laryngoscope·2026
Same journal

Laryngeal Nerve Protection Devices in Thyroid Surgery: A Systematic Review and Evidence Synthesis.

The Laryngoscope·2026
Same journal

Practice Patterns for the Management of Pediatric oSDB: What Is the Current National Landscape?

The Laryngoscope·2026
See all related articles

This study on primary subglottic cancer found that combination therapy (surgery and radiotherapy) significantly improved disease-free survival compared to radiotherapy alone. Early-stage disease was more common, but advanced stages also occurred.

Area of Science:

  • Otolaryngology
  • Oncology

Background:

  • Primary subglottic cancer is a rare diagnosis, representing 1.8% of laryngeal cancers.
  • Epidermoid carcinoma is the most common type, accounting for 71.8% of cases.

Purpose of the Study:

  • To review treatment outcomes for primary subglottic cancer.
  • To evaluate the efficacy of different treatment modalities.

Main Methods:

  • Retrospective review of 39 patients diagnosed between 1955 and 1988.
  • Analysis of treatment approaches including radiotherapy alone, surgery alone, and combination therapy.

Main Results:

  • Overall 5-year survival was 57.7%, with disease-free survival at 46.2%.
  • Disease-free survival rates were 22.2% for radiotherapy alone, 41.7% for surgery alone, and 100% for combination therapy.

Related Experiment Videos

  • Combination therapy demonstrated significantly higher disease-free survival (P < .01) than radiotherapy alone.

    • Conclusions:

    • Combination therapy offers superior outcomes for primary subglottic cancer.
    • Further research into optimal treatment strategies for this rare cancer is warranted.